Progression‐free survival · people with metastatic breast cancer
Capecitabine‐containing regimens probably leads to lower progression‐free survival (PFS)median compared with chemotherapy regimens without capecitabine (moderate certainty).
1 finding from 1 review
PFS: hormone receptor‐positivemedian · people with metastatic breast cancer
Capecitabine‐containing regimens probably leads to lower PFS: hormone receptor‐positivemedian compared with chemotherapy regimens without capecitabine (moderate certainty).
1 finding from 1 review
PFS: hormone receptor‐negativemedian · people with metastatic breast cancer
Capecitabine‐containing regimens showed no clear difference in PFS: hormone receptor‐negativemedian compared with chemotherapy regimens without capecitabine (moderate certainty).
1 finding from 1 review
Objective response rate · people with metastatic breast cancer
Capecitabine‐containing regimens showed no clear difference in objective response rate compared with chemotherapy regimens without capecitabine (moderate certainty).
1 finding from 1 review
Quality of life · people with metastatic breast cancer
1 finding from 1 review
Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
1 finding from 1 review
Proportion of children with inadequate level of sedation (Ramsay score below 4) · children undergoing neurodiagnostic procedures
Chloral hydrate oral (70 mg/kg) may leads to lower proportion of children with inadequate level of sedation (Ramsay… compared with promethazine oral (1 mg/kg) (low certainty).
1 finding from 1 review
Proportion of children who had sedation failure or inadequate level of sedation · children undergoing neurodiagnostic procedures
Chloral hydrate oral (70 mg/kg) probably leads to lower proportion of children who had sedation failure or inadequate level… compared with promethazine oral (1 mg/kg) (moderate certainty).
1 finding from 1 review
Number of children with clinical adverse event: behavioural change · children undergoing neurodiagnostic procedures
Chloral hydrate oral (70 mg/kg) showed no clear difference in number of children with clinical adverse event: behavioural change compared with promethazine oral (1 mg/kg) (moderate certainty).
1 finding from 1 review
Number of children with clinical adverse event: nausea or vomiting · children undergoing neurodiagnostic procedures
Chloral hydrate oral (70 mg/kg) showed no clear difference in number of children with clinical adverse event: vomiting or nausea compared with promethazine oral (1 mg/kg) (low certainty).
1 finding from 1 review
Circuit lifespan · AKI patients receiving CKRT
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).
1 finding from 1 review
Recovery of kidney function · AKI patients receiving CKRT
Surface‐modified showed no clear difference in recovery of kidney function compared with standard double‐lumen catheter with identical geometry and flow design (low certainty).
1 finding from 1 review
Vascular access complications · AKI patients receiving CKRT
Surface‐modified showed no clear difference in vascular access complications compared with standard double‐lumen catheter with identical geometry and flow design (low certainty).
1 finding from 1 review
Vaginal birth within 24 hours · women in the third trimester for induction of labour.
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with mechanical methods (low certainty).
1 finding from 1 review
Caesarean section · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower caesarean section compared with mechanical methods (low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour.
Oral misoprostol showed no clear difference in uterine hyperstimulation with fetal heart rate changes compared with mechanical methods (low certainty).
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower oxytocin augmentation compared with mechanical methods (low certainty).
1 finding from 1 review